Chemaxon blog

26 10 2023
3 minutes

Automated model building using only relevant features

Accelerate your drug discovery process: Create multiple models effortlessly with Trainer Engine and...

27 09 2023
3 minutes

What is Kanban and how does it optimize early drug discovery projects?

Discover how Kanban optimizes early drug discovery projects. Visualize workflow, improve...

14 09 2023
< 1 minute

On-demand Webinar - Successful Hypothesis and Synthesis Management with Design Hub

In this webinar Dora Barna presents how Design Hub facilitates data-driven decision making and...

05 07 2023
2 minutes

Overcome challenges in collaborating with CROs - Documentation

Optimize CRO collaboration and documentation challenges with Design Hub's streamlined solutions for...

28 06 2023
< 1 minute

Overcome challenges in collaborating with CROs - Aspects of collaboration

Compound prioritization collaboration in the pharmaceutical industry with Chemaxon's Design Hub - a...

21 06 2023
2 minutes

Overcome challenges in collaborating with CROs - Communication

Streamline communication and accelerate collaboration with CROs using Chemaxon's Design Hub. Learn...

14 06 2023
< 1 minute

Overcome challenges in collaborating with CROs - The Technical standpoint

Simplify collaboration with CROs using Chemaxon's Design Hub. Streamline project management,...

12 05 2023
3 minutes

Key Properties in Drug Design | Predicting Lipophilicity, pKa and Solubility

Discover how Chemaxon's predictive models for lipophilicity, pKa, and solubility can accurately...

12 04 2023
< 1 minute

EDB GlobalConnect Certified Technology Partnership

We are excited to announce that Chemaxon is now an EDB GlobalConnect Certified Technology Partner.

04 01 2023
< 1 minute

Response to CVE-2022-1471

Chemaxon's response to CVE-2022-1471 vulnerability.

16 12 2022
< 1 minute

Life at Chemaxon - a Hungarian video at our head office

A video about the life at Chemaxon by videoblogger Csaba Magyarósi.

25 10 2022
< 1 minute

Response to CVE-2022-42889

Chemaxon's response to CVE-2022-42889 vulnerability.